J. Safra Sarasin Holding Ag Gilead Sciences, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.76 Trillion
- Q3 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 822,734 shares of GILD stock, worth $79.8 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
822,734
Previous 838,143
1.84%
Holding current value
$79.8 Million
Previous $57.5 Billion
19.99%
% of portfolio
1.2%
Previous 1.05%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,913Shares Held
1.02BCall Options Held
12MPut Options Held
9.03M-
Black Rock Inc. New York, NY121MShares$11.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$7.4 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.86 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.76 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $122B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...